Russell Investments Group’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
PHP
VCM
KCM
RHJA
Russell Investments Group's OPRX Position: Q1 2026 in Review
Russell Investments Group reduced its OptimizeRx (OPRX) stake by 57% in Q1 2026, selling an estimated $1.52M and leaving 125,493 shares worth $788K. The position accounts for ﹤0.01% of the portfolio, ranked #2324.
Russell Investments Group first reported a position in OPRX in Q3 2018 and has held it in 27 quarters since. The position peaked at $7.09M in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.
- Russell Investments Group held 125,493 shares of OptimizeRx worth $788K as of Q1 2026.
- Russell Investments Group sold 163,567 OptimizeRx shares in Q1 2026, an estimated $1.52M.
- OptimizeRx made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2324 holding.
- Russell Investments Group first reported a position in OptimizeRx in Q3 2018 and has held it in 27 quarters since.
- Russell Investments Group's OptimizeRx position peaked at $7.09M in Q3 2021.
- 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.